Trailing-twelve-month (TTM) revenue is $36.77 Million with a year-over-year growth of (58.40%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-08-31 | $7,894,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-09 |
| Q4 FY2025Period ended 2025-11-30 | $13,577,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-28 |
| Q1 FY2026Period ended 2026-02-28 | $6,252,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-08 |
| Q2 FY2026Period ended 2026-05-31 | $9,043,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-09 |
| TTM revenue | $36,766,000 |
Current P/S: $2,345,473,200 market capitalization ÷ $36,766,000 TTM revenue = 63.79x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-05-31): $9.04M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:07:55.746Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-11-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-11-30 · USD | FY20242024-11-30 · USD | FY20252025-11-30 · USD |
|---|---|---|---|
| Collaboration Revenue | $57M | $55M | $54M |
| License Revenue | $20M | N/A | $30M |
$36.77M
$36.77 Million
(58.40%)
vs. $88.38M a year ago (TTM)
+9.96%
5 Year compound annual growth rate
1 Year
(58.40%)
3 Year
(15.50%)
5 Year
+9.96%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $83.98M | +$29.43M | +53.95% |
| 2024 | $54.55M | ($22.44M) | (29.15%) |
| 2023 | $76.99M | +$38.36M | +99.31% |
| 2022 | $38.63M | +$8.88M | +29.84% |
| 2021 | $29.75M | +$11.93M | +66.95% |
| 2020 |
TTM Growth
(58.40%)
3-Year CAGR
(15.50%)
5-Year CAGR
+9.96%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:07:55.746Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $17.82M |
| ($13.29M) |
| (42.73%) |
| 2019 | $31.11M | ($6.33M) | (16.91%) |
